STOCK TITAN

Innerscope Hear Stock Price, News & Analysis

INND OTC Link

Company Description

InnerScope Hearing Technologies Inc. (OTC: INND) is a publicly traded company focused on the Over-the-Counter (OTC) hearing health and broader digital health markets. According to company disclosures, InnerScope is a manufacturer and distributor of OTC hearing aids, hearing aid accessories, and hearing health-related products, with a stated mission of addressing the demand for affordable hearing solutions for people with hearing impairment in North America and globally.

InnerScope positions itself in the OTC hearing aid space through a combination of business-to-business (B2B) and business-to-consumer (B2C) models. The company highlights a B2B wholesale distribution strategy that places its hearing products with major retailers, pharmacy chains, and healthcare service companies. These channels include online platforms and, in some cases, in-store presence at large U.S. retail and pharmacy brands. InnerScope states that this approach is intended to reduce barriers that have historically limited access to hearing aids, such as prescription requirements and higher-priced traditional devices.

Business model and distribution strategy

Company materials describe InnerScope’s core business as the design, manufacture, and distribution of OTC hearing aids and related hearing products. InnerScope reports that it has shifted from a primarily direct-to-consumer model to a focus on B2B wholesale distribution following the U.S. Food and Drug Administration’s OTC hearing aid ruling that enabled adults with perceived mild to moderate hearing loss to purchase hearing aids without a prescription or professional fitting.

InnerScope’s B2B model centers on supplying its branded hearing products to major retailers, national pharmacy chains, and healthcare service companies. The company reports distribution of its HearingAssist and iHEAR branded products through multiple online and retail channels, including large U.S. “big box” retailers, pharmacy websites, and healthcare distributors that serve thousands of pharmacy locations. InnerScope also reports the deployment of free-standing and counter-top product displays in retail vision centers and pharmacies, as well as pharmacy counter placards and brochures distributed through major healthcare distributors.

In addition to physical and online product placement, InnerScope describes the use of automated point-of-sale self-administered hearing screening kiosks in pharmacies. These kiosks offer customers a short hearing screening test with instant results and information about OTC hearing aid options available through the retailer. The company also notes an online hearing screening test version for retailer websites. InnerScope states that it operates an internal hearing care professional customer service call center staffed with Doctors of Audiology and licensed hearing professionals to support customers in adjusting devices and addressing hearing-related questions.

Brands, acquisitions, and technology assets

InnerScope’s product portfolio is centered on two primary brands: HearingAssist and iHEAR. Company disclosures state that HearingAssist has been active in the direct-to-consumer hearing aid market since 2008 and has sold hundreds of thousands of hearing aids. InnerScope reports that HearingAssist is positioned as an affordable OTC hearing aid brand and that its devices are offered through major U.S. retailers and pharmacy chains, including their online platforms.

InnerScope also reports the acquisition of iHear Medical Inc., described as a direct-to-consumer cloud-based hearing solution provider. Through this acquisition, InnerScope states it gained access to an R&D facility, a team of engineers, and more than 40 hearing-related patents. The company indicates that these assets support the development of advanced OTC hearing products and help position InnerScope within the emerging OTC hearing aid market.

In addition, InnerScope has disclosed a partnership with Atlazo Inc., characterized as a semiconductor innovator for next-generation AI smart devices. The company states that this partnership, together with its acquisitions, is intended to support the development and sale of advanced hearing products through major retailers and pharmacy chains.

Retail and pharmacy channel presence

According to multiple company press releases, InnerScope’s HearingAssist and iHEAR branded products are available through a broad set of retail and wholesale distribution channels. These include online listings with large U.S. retailers and pharmacy chains and distribution through major healthcare wholesalers. Company disclosures also reference representation across thousands of store locations via these partners.

InnerScope has specifically reported launches of HearingAssist OTC rechargeable hearing aids on Target.com, Walgreens.com, and CVS.com, along with selected in-store placements at certain pharmacy locations. It has also reported distribution through vision centers associated with a major U.S. retailer, as well as availability via healthcare distributors and grocery and pharmacy groups that collectively represent many thousands of store locations. InnerScope highlights that this network is part of its strategy to expand market penetration and category presence in the OTC hearing aid segment.

InnerScope describes itself as operating in the OTC hearing aid category, with a focus on rechargeable OTC hearing aids and hearing health-related products. Company materials state that its OTC hearing aids are FDA-registered and that certain models offer features such as app-based personalization and wireless audio streaming. InnerScope’s product range also includes hearing aid accessories and other hearing-related supplies, as well as hearing health products offered through its retail and online channels.

The company emphasizes affordability and accessibility as key aspects of its offering, positioning its OTC hearing aids as lower-cost alternatives to traditional prescription hearing aids sold through hearing healthcare professionals. InnerScope’s communications repeatedly reference the large number of people in North America and globally with hearing impairment and present its products as addressing this unmet demand.

Digital health and online initiatives

Beyond physical retail distribution, InnerScope has reported initiatives in digital health and online commerce. The company announced the grand opening of OTCHealthMart.com, described as an online platform offering over-the-counter health and wellness products. According to the company, this platform includes OTC hearing aids under the HearingAssist and iHEAR brands and a specialty line of vitamins and health supplements for older adults, with plans to expand into additional health-related product categories.

InnerScope also highlights its involvement with OTCHealth Inc., which it describes as delivering digital health solutions and over-the-counter medical, health, and wellness products online and through major U.S. pharmacies and retail chains. Company disclosures state that OTCHealth’s offerings include Bluetooth app-controlled OTC hearing aids and an AI-based web hearing screening test accessible via kiosks or online.

Strategic alliance with Ainnova Tech and OTCHealth

In a later announcement, InnerScope reported a strategic alliance related to the pending acquisition of OTCHealth Inc. by Ainnova Tech Inc., described as a global company focused on AI-powered early disease detection. InnerScope states that it is an equity owner in OTCHealth and that, through this transaction, it will transition the majority of its day-to-day sales operations, including retail agreements with major U.S. retailers and healthcare service companies, to OTCHealth.

According to the company, this structure is intended to allow OTCHealth, as a subsidiary of Ainnova, to maximize the value of existing retail partnerships and deliver preventive health and hearing solutions to consumers. InnerScope reports that, through this transaction, it expects to receive equity and profit participation in both OTCHealth and Ainnova Tech. The company states that it plans to focus its resources on global research and development and technology innovation in hearing technologies, with these innovations to be integrated into OTCHealth’s offerings.

Investor relations and communications

InnerScope’s shares trade on the OTC market under the symbol INND. The company has engaged external investor relations and digital marketing firms to support communications with shareholders and the broader market. It has also referenced plans to enhance its reporting status and has publicly discussed the engagement of an external audit firm to audit its financial statements for certain past years, with the stated intention to pursue SEC reporting status through a Form 10 filing after completion of those audits.

InnerScope has released financial information through OTC Markets, including an annual financial report that discussed revenues, gross profit, and net profit for a prior full-year period. The company attributes its revenue growth and profitability in that period largely to wholesale distribution agreements linked to its acquisitions of HearingAssist and iHEAR and to increased sales volume of hearing aids.

Position within the OTC hearing aid market

Company communications describe InnerScope as operating in an emerging OTC hearing aid market that was shaped by U.S. regulatory changes allowing adults with hearing loss to purchase hearing aids directly from retailers and pharmacies. InnerScope emphasizes its wholesale distribution network, its HearingAssist and iHEAR brands, and its technology assets from acquisitions and partnerships as factors that it believes position the company within this market. It also points to the relatively limited number of competitors it identifies in the OTC hearing aid space as part of its narrative about market opportunity.

FAQs about InnerScope Hearing Technologies (INND)

  • What does InnerScope Hearing Technologies do?
    InnerScope Hearing Technologies Inc. states that it manufactures and distributes OTC hearing aids, hearing aid accessories, and hearing health-related products. The company focuses on making hearing solutions available through major retailers, pharmacy chains, healthcare service companies, and online channels.
  • What are InnerScope’s main brands?
    According to company disclosures, InnerScope’s primary brands are HearingAssist and iHEAR. HearingAssist is described as an established direct-to-consumer hearing aid brand with hundreds of thousands of devices sold, while iHEAR is associated with a cloud-based hearing solution platform and a portfolio of hearing-related patents.
  • How does InnerScope reach customers?
    InnerScope reports that it uses a B2B wholesale distribution model to place its products with major retailers, pharmacy chains, and healthcare service companies, as well as online platforms operated by these partners. It also references self-administered hearing screening kiosks in pharmacies and online hearing screening tools that direct consumers to OTC hearing aid options.
  • What role do acquisitions play in InnerScope’s business?
    The company states that it acquired iHear Medical Inc. and HearingAssist, gaining access to patents, an R&D facility, engineering teams, and an established customer base. These acquisitions are presented as central to InnerScope’s strategy to offer advanced and affordable OTC hearing products through large retail and pharmacy networks.
  • What is InnerScope’s relationship with OTCHealth and Ainnova Tech?
    InnerScope reports that it is an equity owner in OTCHealth Inc. and that it plays a role in a pending transaction in which Ainnova Tech Inc. plans to acquire OTCHealth. InnerScope states that it intends to transition most of its day-to-day sales operations and retail agreements to OTCHealth, while focusing on global R&D and technology innovation in hearing technologies.
  • How does InnerScope support users of its hearing products?
    Company materials describe an internal hearing care professional customer service call center staffed with Doctors of Audiology and licensed hearing professionals. This team is presented as providing assistance to customers in adjusting OTC hearing aids and optimizing their use in different listening environments.
  • What markets does InnerScope target?
    InnerScope’s communications reference people with hearing impairment in North America and globally, including tens of millions of adults in the United States. The company focuses on adults who can benefit from OTC hearing aids sold through retail and pharmacy channels without the need for a prescription or in-person fitting.
  • How does InnerScope describe its competitive environment?
    In interviews and releases, InnerScope characterizes the OTC hearing aid market as an emerging category with a relatively small number of competitors. The company highlights its wholesale distribution footprint, brand recognition through HearingAssist and iHEAR, and its technology assets as factors it believes support its position in this market.

Stock Performance

$—
0.00%
0.00
Last updated:
-96.21%
Performance 1 year
$146.9K

SEC Filings

No SEC filings available for Innerscope Hear.

Financial Highlights

$166K
Revenue (TTM)
-$5.0M
Net Income (TTM)
-$524K
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Short interest in Innerscope Hear (INND) currently stands at 1.5 thousand shares, down 99.1% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 94.9%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months
Loading days to cover data...

Days to cover for Innerscope Hear (INND) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

Frequently Asked Questions

What is the current stock price of Innerscope Hear (INND)?

The current stock price of Innerscope Hear (INND) is $0.0008 as of March 5, 2026.

What is the market cap of Innerscope Hear (INND)?

The market cap of Innerscope Hear (INND) is approximately 146.9K. Learn more about what market capitalization means .

What is the revenue (TTM) of Innerscope Hear (INND) stock?

The trailing twelve months (TTM) revenue of Innerscope Hear (INND) is $166K.

What is the net income of Innerscope Hear (INND)?

The trailing twelve months (TTM) net income of Innerscope Hear (INND) is -$5.0M.

What is the operating cash flow of Innerscope Hear (INND)?

The operating cash flow of Innerscope Hear (INND) is -$524K. Learn about cash flow.

What is the profit margin of Innerscope Hear (INND)?

The net profit margin of Innerscope Hear (INND) is -2982.2%. Learn about profit margins.

What is the operating margin of Innerscope Hear (INND)?

The operating profit margin of Innerscope Hear (INND) is -740.0%. Learn about operating margins.

What is the gross margin of Innerscope Hear (INND)?

The gross profit margin of Innerscope Hear (INND) is 58.6%. Learn about gross margins.

What is the current ratio of Innerscope Hear (INND)?

The current ratio of Innerscope Hear (INND) is 0.00, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Innerscope Hear (INND)?

The gross profit of Innerscope Hear (INND) is $97K on a trailing twelve months (TTM) basis.

What is the operating income of Innerscope Hear (INND)?

The operating income of Innerscope Hear (INND) is -$1.2M. Learn about operating income.